Correction: Production of IL-8, VEGF and Elastase by Circulating and Intraplaque Neutrophils in Patients with Carotid Atherosclerosis (PLoS ONE (2015) 10: 4 (e0124565) DOI: 10.1371/journal.pone.0124565);Production of IL-8, VEGF and elastase by circulating and intraplaque neutrophils in patients with carotid atherosclerosis

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Marino, Franca ^a   Tozzi, Matteo ^a   Schembri, Laura ^a   Ferraro, Stefania ^a   Tarallo, Antonino ^a   Scanzano, Angela ^a   Legnaro, Massimiliano ^a   Castelli, Patrizio ^a   Cosentino, Marco ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARCINOEMBRYONIC ANTIGEN; CELL PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ELASTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 8; MESSENGER RNA; PROTEIN CD66B; UNCLASSIFIED DRUG; VASCULOTROPIN; CD66 ANTIGENS; CELL ADHESION MOLECULE; IL8 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PANCREATIC ELASTASE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGED; ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CELL DENSITY; CELL ISOLATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE COURSE; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; NEUTROPHIL; NEUTROPHIL COUNT; PROTEIN SYNTHESIS; RNA ANALYSIS; VENOUS BLOOD; ATHEROSCLEROTIC PLAQUE; BIOSYNTHESIS; CAROTID ARTERY DISEASE; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

AGED; ANTIGENS, CD; CAROTID ARTERY DISEASES; CELL ADHESION MOLECULES; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; MALE; NEUTROPHILS; PANCREATIC ELASTASE; PLAQUE, ATHEROSCLEROTIC; REAL-TIME POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84929483821     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0181389     Document Type: Erratum

References (42)

1. Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell. 2001; 104: 503-16. PMID: 11239408
2. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011; 12: 204-12. doi: 10.1038/ni.2001 PMID: 21321594
3. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004; 84: 1381-1478. PMID: 15383655
4. Mocsai A. Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med. 2013; 7: 1283-99.
5. Baetta R, Corsini A. Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives. Atherosclerosis. 2010, 210: 1-13. doi: 10.1016/j.atherosclerosis.2009.10.028 PMID: 19931081
6. van Leeuwen M, Gijbels MJ, Duijvestijn A, Smook M, van de Gaar MJ, Heeringa P, et al. Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR-/- mice. Arterioscler Thromb Vasc Biol. 2008; 28: 84-89. PMID: 17991873
7. Guasti L, Marino F, Cosentino M, Cimpanelli M, Maio RC, Klersy C, et al. Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk subjects: a longitudinal study. J. Hypertens. 2006; 24: 2423-2430. PMID: 17082725
8. Marino F, Guasti L, Cosentino M, Ferrari M, Rasini E, Maio RC, et al. Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin. J Cardiovasc Pharmacol 2007; 49: 299-305. PMID: 17513949
9. Guasti L, Marino F, Cosentino M, Maio RC, Rasini E, Castiglioni L, et al. Prolonged statin-induced reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up. Eur H J. 2008; 29: 1118-1126.
10. Khuseyinova N, Koenig W. Biomarkers of outcome from cardiovascular disease. Curr Opin Crit Care. 2006; 12: 412-9. PMID: 16943718
11. Zernecke A, Bot I, Djalali-Talab Y, Shagdarsuren E, Bidzhekov K, Meiler S, et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res. 2008; 102: 209-217. PMID: 17991882
12. Quinn K, Henriques M, Parker T, Slutsky AS, Zhang H. Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases. Am J Physiol Heart Circ Physiol 2008; 295: H1817-H1824. doi: 10.1152/ajpheart.00472.2008 PMID: 18805897
13. Guasti L, Dentali F, Castiglioni L, Maroni L, Marino F, Squizzato A, et al. Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. A systematic review on more than 34,000 subjects. Thromb Haemost. 2011; 106: 591-9. doi: 10.1160/TH11-02-0096 PMID: 21866299
14. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002; 106: 2894-900. PMID: 12460868
15. Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circ Res. 2012; 110: 875-88. doi: 10.1161/CIRCRESAHA.111.257535 PMID: 22427325
16. Della Bona R, Cardillo MT, Leo M, Biasillo G, Gustapane M, Trotta F, et al. Polymorphonuclear neutrophils and instability of the atherosclerotic plaque: a causative role? Inflamm Res. 2013, 62: 537-50. doi: 10.1007/s00011-013-0617-0 PMID: 23549741
17. Benabid R, Wartelle J, Malleret L, Guyot N, Gangloff S, Lebargy F, et al. Neutrophil elastase modulates cytokine expression: contribution to host defense against Pseudomonas aeruginosa-induced pneumonia. J Biol Chem. 2012; 287: 34883-94. doi: 10.1074/jbc.M112.361352 PMID: 22927440
18. Henriksen PA, Sallenave JM. Human neutrophil elastase: mediator and therapeutic target in atherosclerosis. Int J Biochem Cell Biol. 2008; 40: 1095-100. doi: 10.1016/j.biocel.2008.01.004 PMID: 18289916
19. Baggiolini M. Chemokines in pathology and medicine. J Intern Med. 2001; 250:91-104. PMID: 11489059
20. Boisvert WA. The participation of chemokines in atherosclerosis. Discov Med. 2004; 4: 288-92. PMID: 20704961
21. Marino F, Guasti L, Tozzi M, Maio RC, Castiglioni L, Rasini E, et al. Angiotensin Type-1 receptor expression abd Interleukin-8 production In polymorphonuclear leukocytes of patients with peripheral arterial disease. J Cardiovasc Pharmacol. 2009; 54: 520-5. doi: 10.1097/FJC.0b013e3181bfadfd PMID: 19755917
22. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008; 14: 6735-41. doi: 10.1158/1078-0432.CCR-07-4843 PMID: 18980965
23. Quigley JP, Deryugina EI. Combating angiogenesis early: potential of targeting tumor-recruited neutrophils in cancer therapy. Future Oncol. 2012; 8: 5-8. doi: 10.2217/fon.11.133 PMID: 22149028
24. Tecchio C, Cassatella MA. Neutrophil-derived cytokines involved in physiological and pathological angiogenesis. Chem Immunol Allergy. 2014; 99: 123-37. doi: 10.1159/000353358 PMID: 24217606
25. Holm PW, Slart RH, Zeebregts CJ, Hillebrands JL, Tio RA. Atherosclerotic plaque development and instability: a dual role for VEGF. Ann. Med. 2009; 41: 257-64. doi: 10.1080/07853890802516507 PMID: 19089693
26. Moreno PR, Purushothaman M, Purushothaman KR. Plaque neovascularization: defense mechanisms, betrayal, or a war in progress. Ann N Y Acad Sci 2012; 1254: 7-17. doi: 10.1111/j.1749-6632.2012.06497.x PMID: 22548565
27. Golledge J, Greenhalgh RM, Davies AH. The symptomatic carotid plaque. Stroke. 2000; 31: 774-81. PMID: 10700518
28. Golledge J, Cuming R, Ellis M, Davies AH, Greenhalgh RM. Carotid plaque characteristics and presenting symptoms. Br J Surg. 1997; 84: 1697-701. PMID: 9448618
29. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497. PMID: 11368702
30. de Weert TT, de Monyé C, Meijering E, Booij R, Niessen WJ, Dippel DW, et al. Assessment of atherosclerotic carotid plaque volume with multidetector computed tomography angiography. Int J Cardiovasc Imaging. 2008 24: 751-9. doi: 10.1007/s10554-008-9309-1 PMID: 18373211
31. Saba L, Piga M, Raz E, Farina D, Montisci R. Carotid artery plaque classification: does contrast enhancement play a significant role? AJNR Am J Neuroradiol. 2012; 33: 1814-7. doi: 10.3174/ajnr.A3073 PMID: 22555579
32. Saba L, Montisci R, Sanfilippo R, Mallarini G. Multidetector row CT of the brain and carotid artery: a correlative analysis. Clin Radiol. 2009; 64: 767-78. doi: 10.1016/j.crad.2009.03.009 PMID: 19589415
33. Liapis CD, Bell PR, Mikhailidis D, Sivenius J, Nicolaides A, Fernandes E, et al. ESVS Guidelines Collaborators. ESVS Guidelines. Invasive treatment for Carotid Stenosis according to indications techniques suggested by the Eur J Vasc Endovasc Surg 2009; 37: S1-S19. doi: 10.1016/j.ejvs.2009.03.028 PMID: 19464203
34. Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, et al. International Union of Basic and Clinical pharmacology. LXXIII: Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev. 2009; 61: 119-61. doi: 10.1124/pr.109.001578 PMID: 19498085
35. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352: 1685-95. PMID: 15843671
36. Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 2010; 122: 1837-45. doi: 10.1161/CIRCULATIONAHA.110.961714 PMID: 20956207
37. Rotzius P, Thams S, Soehnlein O, Kenne E, Tseng CN, Björkström NK, et al. Distinct infiltration of neutrophils in lesion shoulders in ApoE-/- mice. Am J Pathol. 2010; 177: 493-500. doi: 10.2353/ajpath.2010.090480 PMID: 20472897
38. Ionita MG, van den Borne P, Catanzariti LM, Moll FL, de Vries JP, Pasterkamp G, et al. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol 2010; 30: 1842-8. doi: 10.1161/ATVBAHA.110.209296 PMID: 20595650
39. Ho-Tin-Noé B, Michel JB. Initiation of angiogenesis in atherosclerosis: smooth muscle cells as mediators of the angiogenic response to atheroma formation. Trends Cardiovasc Med 2011; 21: 183-7. doi: 10.1016/j.tcm.2012.05.007 PMID: 22867696
40. Simonini A, Moscucci M, Muller DW, Bates ER, Pagani FD, Burdick MD, et al. IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation 2000; 101: 1519-26. PMID: 10747344
41. Dorweiler B, Torzewski M, Dahm M, Kirkpatrick CJ, Lackner KJ, Vahl CF. Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima. Thromb Haemost. 2008; 99: 373-81. doi: 10.1160/TH07-06-0387 PMID: 18278188
42. Mayer FJ, Gruenberger D, Schillinger M, Mannhalter C, Minar E, Koppensteiner R, et al. Prognostic value of neutrophils in patients with asymptomatic carotid artery disease. Atherosclerosis. 2013; 231: 274-80. doi: 10.1016/j.atherosclerosis.2013.10.002 PMID: 24267239